Can provider education and smarter policy close the biosimilars gap?

STAT Brand Studio
18/09/2025 6 min
Can provider education and smarter policy close the biosimilars gap?

Listen "Can provider education and smarter policy close the biosimilars gap?"

Descargar episodio

Episode Synopsis

Biosimilars are driving down drug costs, expanding access to critical treatments, and creating space for future innovation. In this episode, Linda Choi MacDonald, EVP and Global Head of Commercial at Samsung Bioepis, discusses the challenges slowing biosimilar development — and how policy reforms, stronger incentives, and provider education can help close the gap.



: https://www.statnews.com/sponsor/2025/09/18/can-provider-education-and-smarter-policy-close-the-biosimilars-gap/

More episodes of the podcast STAT Brand Studio

“Taking possibility back” across oncology’s toughest frontiers 09/10/2025
From research to advocacy: A new fellowship honors Stephen Harrison’s vision in MASH research 25/08/2025
Supporting science from bench to bioproduction 12/06/2025
Building the future of life sciences in NYC 22/05/2025
Puerto Rico’s competitive edge: Workforce, incentives, and cutting-edge infrastructure 20/03/2025
Fighting colorectal cancer disparities with real-world data 02/01/2025
Three-year degree expands access to medical education and fast-tracks specialty study 04/12/2024
Top-ranked health system launches wide-ranging molecular oncology program 06/11/2024
Approaching patient care with understanding, respect, and humility 09/10/2024
STAT Summit 2024 07/08/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA